SIREN : 817425143
MRN is a French company founded 10 years ago, specialized in the sector Activités des sociétés holding. Based in TOURS (37000), this company of category PME shows in 2023 a revenue of 112 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | 111 600 € | N/C | N/C | N/C | N/C | N/C | N/C |
| Net income | 29 407 € | 39 769 € | 48 377 € | 66 625 € | 36 034 € | 65 726 € | 53 192 € | 27 410 € | 25 401 € |
| EBITDA | N/C | N/C | 10 544 € | N/C | N/C | -1 996 € | -2 695 € | -1 873 € | -1 745 € |
| Net margin | N/C | N/C | 43.3% | N/C | N/C | N/C | N/C | N/C | N/C |
In 2025, MRN generates positive net income of 29 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 25 k€ -> 29 k€.
29 407 €
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 79%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
23.013%
79.056%
In 2025, the debt ratio of MRN (23.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of MRN (79.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2023, the repayment capacity of MRN (1.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 1837.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1837.551
In 2025, the liquidity ratio of MRN (1837.55) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of MRN (3.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions). This range of 11 726€ to 361 390€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MRN with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of MRN in 2023 is 112 k€.
Yes, MRN generated a net profit of 29 k€ in 2025.
The headquarters of MRN is located in TOURS (37000), in the department Indre-et-Loire.
The tax return of MRN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MRN operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.